Natalia A. Kuzmina - Concepedia

Concepedia

Author

Natalia A. Kuzmina

The University of Texas Medical Branch at Galveston ORCID

Also Known As

Kawaoka, Yoshihiro, Kuzmina, Natalia A., N. Kuzmina, Natalia A Kuzmina, Natalia A. Kuzmina, Natalia Kuzmina

63

Publications

1.9K

Citations

27

H-Index

43

Concepts

All Affiliations

The University of Texas Medical Branch at Galveston Galveston College Vanderbilt University Medical Center Scripps Research Institute Centers for Disease Control and Prevention

NA

About

Natalia A. Kuzmina is an author at The University of Texas Medical Branch at Galveston specializing in medicine, virology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	21	970
2	Public Health	3	3	244
3	Allergy	3	3	98
4	Social Sciences	1	1	44
5	Biology	1	1	44

Natalia A. Kuzmina

×

37

Publications

1.9K

Citations

27

H-Index

	Year	Citations
Molecular Inferences Suggest Multiple Host Shifts of Rabies Viruses from Bats to Mesocarnivores in Arizona during 2001–2009 Ivan V. Kuzmin, Mǎng Shī, Lillian A. Orciari, PLoS Pathogens	2012	200
Cross-Reactive and Potent Neutralizing Antibody Responses in Human Survivors of Natural Ebolavirus Infection Andrew I. Flyak, Xiaoli Shen, Charles D. Murin, Cell VaccinationVaccine DevelopmentVaccine TargetImmunologyAntiviral Response	2016	178
SARS-CoV-2 seropositivity and subsequent infection risk in healthy young adults: a prospective cohort study Andrew G. Letizia, Yongchao Ge, Sindhu Vangeti, The Lancet Respiratory Medicine Sars-cov-2 SeropositivityLong CovidCovid-19 PandemicHealthy Young AdultsCovid-19 Epidemiology	2021	170
Antibody-Dependent Enhancement of Ebola Virus Infection by Human Antibodies Isolated from Survivors Natalia A. Kuzmina, Patrick Younan, Pavlo Gilchuk, Cell Reports	2018	95
Analysis of a Therapeutic Antibody Cocktail Reveals Determinants for Cooperative and Broad Ebolavirus Neutralization Pavlo Gilchuk, Charles D. Murin, Jacob C. Milligan, Immunity VaccinationViral DiagnosticsViral PathogenesisImmunologyAntiviral Response	2020	92
Broadly neutralizing antibodies from human survivors target a conserved site in the Ebola virus glycoprotein HR2–MPER region Andrew I. Flyak, Natalia A. Kuzmina, Charles D. Murin, Nature Microbiology Emerging Infectious DiseasesViral PathogenesisImmunologyAntiviral ResponseVirology	2018	87
Multifunctional Pan-ebolavirus Antibody Recognizes a Site of Broad Vulnerability on the Ebolavirus Glycoprotein Pavlo Gilchuk, Natalia A. Kuzmina, Philipp A. Ilinykh, Immunity	2018	83
Non-neutralizing Antibodies from a Marburg Infection Survivor Mediate Protection by Fc-Effector Functions and by Enhancing Efficacy of Other Antibodies Philipp A. Ilinykh, Kai Huang, Rodrigo I. Santos, Cell Host & Microbe Fc-effector FunctionsImmune Effector FunctionsAutoimmune DiseaseHumoral ResponseImmunology	2020	77
COVA1-18 neutralizing antibody protects against SARS-CoV-2 in three preclinical models Pauline Maisonnasse, Yoann Aldon, Aurélien Marc, Nature Communications	2021	54
Phylogenetic and epidemiologic evidence of multiyear incubation in human rabies Torrey A. Boland, Declan McGuone, Jenelle Jindal, Annals of Neurology Genetic AnalysisInfectious Disease EpidemiologyVirus VariantVirus EpidemiologyEmerging Infectious Diseases	2013	53

Page 1